Delivery Order SPE2DB20D1109-SPE2DB24FP58T

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,322,752 units of Vyvanse 60 mg capsules in quantities of 100s, with a ceiling value of $5,172.00. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,162.15, is for the provision of 4,566,357,932 units of the prescription medication Vyvanse 60 mg capsule. The contract is a firm-fixed-price delivery order with a completion date of November 7, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999,...
This is a $1,747.03 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Vyvanse 60 mg capsules. The contract has a firm fixed-price pricing type and a period of performance through September 30, 2024. There is no set-aside designation indicated. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medications to support DLA's medical supply requirements. This contract is likely part of a larger...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $1,665.00 firm fixed price contract is for the delivery of 100 units of Vyvanse 60 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued up to $999,999,999.00 and running through...
This federal contract award, valued at $1,377.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,172,639 units of Vyvanse 60 mg capsules. The contract has a firm fixed price pricing type and an ultimate completion date of May 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $10,833.45 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,778,029 units of Vyvanse 30 mg capsules. The contract has a firm fixed price and an ultimate completion date of January 31, 2023. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026, which...
This is a $7,758 firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The order is for the supply of 4,565,389,732 units of Vyvanse 30 mg capsules. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) worth up to $999,999,999 with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 4,566,564,050 units of 40mg Vyvanse capsules, a prescription medication, at a firm fixed price of $23,792.05. The order has a completion date of November 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,388.96 firm fixed-price delivery order is for the supply of Vyvanse 60 mg capsules in 100-count bottles. The contract has a completion date of November 8, 2024 and was awarded on November 7, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a $1,082.47 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,560,716,962 units of Vyvanse 40 mg capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP58T
    Delivery Order

This is a $5,998.40 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,565,272 units of Vyvanse 60 mg capsules. The award has an ultimate completion date of July 29, 2024 and is a firm fixed price contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is part of that larger IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:28 AM